Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jagoda

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Therapeutic Drug Monitoring|June 1, 1993
Radioimmunoassay for hydroxyphosphinyl-3-hydroxybutanoic acid (SQ 33,600), a hypocholesterolemia agentE Jagoda, B Stouffer, M Ogan, et al.
Therapeutic Drug Monitoring|December 1, 1992
A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracilE Jagoda, M Ogan, B Stouffer, et al.
Folia Morphologica|January 1, 1995
Immunocytochemical studies on endocrine cells of alimentary tract of the pig in the embryonic and fetal period of lifeM Zabel, J Surdyk-Zasada, I Lesisz, et al.
Nuclear Medicine and Biology|August 30, 2000
PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635R E Carson, L Lang, H Watabe, et al.
Nuclear Medicine and Biology|August 1, 1996
A review of new oncotropic tracers for PET imagingL Lang, L Aloj, D O Kiesewetter, et al.
Journal of Medicinal Chemistry|May 7, 1999
Development of fluorine-18-labeled 5-HT1A antagonistsL Lang, E Jagoda, B Schmall, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 14, 2000
Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907H Watabe, M A Channing, M G Der, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteinsL Lang, E Jagoda, C Wu, et al.
Nuclear Medicine and Biology|April 1, 1995
Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptorS S Jurisson, J Pirro, R J DiRocco, et al.
Cancer Research|November 15, 1995
Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenograftsC W Choi, L Lang, J T Lee, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Therapeutic Drug Monitoring|June 1, 1993
Radioimmunoassay for hydroxyphosphinyl-3-hydroxybutanoic acid (SQ 33,600), a hypocholesterolemia agentE Jagoda, B Stouffer, M Ogan, et al.
Therapeutic Drug Monitoring|December 1, 1992
A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracilE Jagoda, M Ogan, B Stouffer, et al.
Folia Morphologica|January 1, 1995
Immunocytochemical studies on endocrine cells of alimentary tract of the pig in the embryonic and fetal period of lifeM Zabel, J Surdyk-Zasada, I Lesisz, et al.
Nuclear Medicine and Biology|August 30, 2000
PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635R E Carson, L Lang, H Watabe, et al.
Nuclear Medicine and Biology|August 1, 1996
A review of new oncotropic tracers for PET imagingL Lang, L Aloj, D O Kiesewetter, et al.
Journal of Medicinal Chemistry|May 7, 1999
Development of fluorine-18-labeled 5-HT1A antagonistsL Lang, E Jagoda, B Schmall, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 14, 2000
Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907H Watabe, M A Channing, M G Der, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteinsL Lang, E Jagoda, C Wu, et al.
Nuclear Medicine and Biology|April 1, 1995
Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptorS S Jurisson, J Pirro, R J DiRocco, et al.
Cancer Research|November 15, 1995
Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenograftsC W Choi, L Lang, J T Lee, et al.
Pageof 2